Abstract
An association between vitamin D deficiency and hypertension has been observed in numerous studies. However, blood pressure improvements resulting from supplementation with vitamin D have been inconsistent. The causal relationship between vitamin D deficiency and hypertension is still unclear and was investigated in this family-based study. A total of 1370 individuals from both vitamin D deficiency and hypertension families were included. First, the heritability of vitamin D deficiency was estimated by the Falconer method. Second, SNPs (single nucleotide polymorphisms) of vitamin D metabolic and functional pathway genes associated with vitamin D deficiency were screened by a family-based association test, and the findings were further verified in nuclear families with vitamin D deficiency. Finally, a family-based association test was applied to investigate the association between selected SNPs associated with vitamin D deficiency and hypertension. The heritability of vitamin D deficiency was 50.4% in this family-based study. Allele C of rs3847987 was a risk factor for vitamin D deficiency (OR: 1.639, 95% CI: 1.170–2.297, P = 0.004). Furthermore, a family-based association of rs3847987 with hypertension was found in both additive and recessive models (P < 0.05). In addition, vitamin D deficiency was associated with hypertension (OR: 1.317, 95% CI: 1.022–1.698, P = 0.033). In conclusion, rs3847987 in the VDR gene was associated with both vitamin D deficiency and hypertension. Therefore, vitamin D deficiency may be a causal factor for hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Roth DE, Abrams SA, Aloia J, Bergeron G, Bourassa MW, Brown KH, et al. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann NY Acad Sci. 2018;1430:44–79.
Kim DH, Meza CA, Clarke H, Kim JS, Hickner RC. Vitamin D and endothelial function. Nutrients. 2020;12:17.
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Kostenberger M, Berisha AT, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74:1498–513.
Cashman KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int. 2020;106:14–29.
Bahrami A, Sadeghnia HR, Tabatabaeizadeh SA, Bahrami-Taghanaki H, Behboodi N, Esmaeili H, et al. Genetic and epigenetic factors influencing vitamin D status. J Cell Physiol. 2018;233:4033–43.
Dastani Z, Li R, Richards B. Genetic regulation of vitamin D levels. Calcif Tissue Int. 2013;92:106–17.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.
Kuchulakanti PK, Chaudhuri JR, Annad U, Samala NR, Tallapaneni L, Balaraju B, et al. Association of serum 25-hydroxyvitamin D levels with primary hypertension: a study from south India. Hypertens Res. 2020;43:389–95.
Vatakencherry RMJ, Saraswathy L. Association between vitamin D and hypertension in people coming for health check up to a tertiary care centre in South India. J Fam Med Prim Care. 2019;8:2061–7.
Liu LS. Joint Comm Guideline R. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16:182–241.
Falconer DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet. 1965;29:51–76.
Griffin FC, Gadegbeku CA, Sowers MR. Vitamin D and subsequent systolic hypertension among women. Am J Hypertens. 2011;24:316–21.
Wee CL, Mokhtar SS, Singh KKB, Rasool AHG. Vitamin D deficiency attenuates endothelial function by reducing antioxidant activity and vascular eNOS expression in the rat microcirculation. Microvasc Res. 2021;138:8.
Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:11.
Sheikh V, Mozaianimonfared A, Gharakhani M, Poorolajal J. Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency: a double-blind randomized clinical trial. J Clin Hypertens. 2020;22:1867–73.
Farapti F, Fadilla C, Yogiswara N. Effects of vitamin D supplementation on 25(OH)D levels and blood pressure in the elderly: a systematic review and meta-analysis. F1000Research. 2020;9:633.
Zhang DD, Cheng C, Wang Y, Sun HL, Yu SC, Xue Y, et al. Effect of vitamin D on blood pressure and hypertension in the general population: an update meta-analysis of cohort studies and randomized controlled trials. Prev Chronic Dis. 2020;17:13.
Choi S, Ko H, Lee K, Sung J, Song YM. Genetic influence on serum 25-hydroxyvitamin D concentration in Korean men: a cross-sectional study. Genes Nutr. 2018;13:9.
Arguelles LM, Langman CB, Ariza AJ, Ali FN, Dilley K, Price H, et al. Heritability and environmental factors affecting vitamin D status in rural Chinese adolescent twins. J Clin Endocrinol Metab. 2009;94:3273–81.
Grzybowska EA, Wilczynska A, Siedlecki JA. Regulatory functions of 3′ UTRs. Biochem Biophys Res Commun. 2001;288:291–5.
Robien K, Butler LM, Wang RW, Beckman KB, Walek D, Koh WP, et al. Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. Br J Nutr. 2013;109:493–502.
Ramos-Lopez E, Jansen T, Ivaskevicius V, Kahles H, Klepzig C, Oldenburg J, et al. Protection from type 1 diabetes by vitamin D receptor haplotypes. In: Sanjeevi CB, Hanafusa T, editors. Immunology of diabetes Iv: progress in our understanding. Annals of the New York Academy of Sciences. 1079. Oxford: Blackwell Publishing; 2006. p. 327–34.
Bouillon R. Genetic and racial differences in the vitamin D endocrine system. Endocrinol Metab Clin North Am. 2017;46:1119–35.
Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol-Renal Physiol. 2005;289:F8–28.
Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21:319–29.
Krasniqi E, Boshnjaku A, Wagner KH, Wessner B. Association between polymorphisms in vitamin D pathway-related genes, vitamin D status, muscle mass and function: a systematic review. Nutrients. 2021;13:24.
te Riet L, van Esch JHM, Roks AJM, van den Meiracker AH, Danser AHJ. Hypertension renin-angiotensin-aldosterone system alterations. CircRes. 2015;116:960–75.
Cosentino N, Campodonico J, Milazzo V, De Metrio M, Brambilla M, Camera M, et al. Vitamin D and cardiovascular disease: current evidence and future perspectives. Nutrients. 2021;13:14.
Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol. 2007;103:416–9.
Budhathoki S, Yamaji T, Iwasaki M, Sawada N, Shimazu T, Sasazuki S, et al. Vitamin D receptor gene polymorphism and the risk of colorectal cancer: a nested case-control study. PLoS ONE. 2016;11:13.
Nunes I, Cavalcante A, Alencar M, Carvalho MDF, Sarmento JLR, Teixeira N, et al. Meta-analysis of the association between the rs228570 vitamin D receptor gene polymorphism and arterial hypertension risk. Adv Nutr. 2020;11:1211–20.
Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr. 2013;52:1771–9.
Liang XH, Chen M, Qu P, Hao G, Huang YS, Chen J, et al. The association of vitamin A and vitamin D with hypertension in children: a case-control study. Int J Hypertens. 2018;2018:8.
Franczyk A, Stolarz-Skrzypek K, Wesolowska A, Czarnecka D. Vitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease. Cardiovas Hematol Disord Drug Targets. 2014;14:34–44.
Acknowledgements
The authors thank all the individuals who participated in the family-based study. We thank to all the participants who participated in this study.
Funding
This work was supported by the National Natural Science Foundation of China (Nos. 81703270, 81872626) and the China Postdoctoral Science Foundation (2020M672298).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bai, L., Qu, C., Feng, Y. et al. Evidence of a casual relationship between vitamin D deficiency and hypertension: a family-based study. Hypertens Res 45, 1814–1822 (2022). https://doi.org/10.1038/s41440-022-01004-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-022-01004-0
Keywords
This article is cited by
-
2023 update and perspectives
Hypertension Research (2024)
-
Association between serum 25-hydroxyvitamin D concentrations and hypertension among adults in North Sudan: a community-based cross-sectional study
BMC Cardiovascular Disorders (2023)